View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsEnphys Acquisition 과거 순이익 실적과거 기준 점검 2/6Enphys Acquisition의 수입은 연평균 -49%의 비율로 감소해 온 반면, Capital Markets 산업의 수입은 연간 6.1% 증가했습니다.핵심 정보-49.05%순이익 성장률-10.61%주당순이익(EPS) 성장률Capital Markets 산업 성장률10.26%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Jun 2024최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Dec 31Enphys Acquisition Corp. Units, Each Consisting of One Class A Ordinary Share and One-Half of One Redeemable Warrant Deleted from OTC EquityEnphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant has been deleted from OTC Equity effective December 30, 2024, due to Unit Separation.공시 • Nov 15Enphys Acquisition Corp. Files Form 15Enphys Acquisition Corp. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant; Class A ordinary shares included as part of the Units, par value $0.0001 per share and Redeemable warrants included as part of the Units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share under the Securities Exchange Act of 1934, as amended.공시 • Oct 17The Staff of NYSE Regulation Files Form 25 with the SEC to Remove Enphys Acquisition's Class A Ordinary Shares, Units from Listing and Registration on the New York Stock ExchangeAs previously reported by Enphys Acquisition Corp. (the ‘Company’), on July 24, 2024, the staff of NYSE Regulation (the ‘Staff’), on behalf of the New York Stock Exchange (‘NYSE’), commenced proceedings to delist the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A Ordinary Shares’), units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant (the ‘Units’), with each warrant exercisable for one share of Class A Ordinary Share of the Company (the ‘Warrants’), and Warrants from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. Trading in the Class A Ordinary Shares, Units, and Warrants on the NYSE was suspended after the market closed on July 24, 2024. Effective as of and since July 25, 2024, the Class A Ordinary Shares, Units, and Warrants have been quoted and traded on the OTC Pink Marketplace under the ticker symbols ‘NFSCF,’ ‘NFSUF,’ and ‘NFSWF,’ respectively. The Company timely exercised its right to a review of the Staff’s determination by a committee (the ‘Committee’) of the Board of Directors of the NYSE. On October 10, 2024, the Company withdrew its request for review by the Committee. On October 10, 2024, the Staff filed a Form 25 with the Securities and Exchange Commission (the ‘SEC’) to remove the Company’s Class A Ordinary Shares, Units, and Warrants from listing and registration on the NYSE. The delisting will be effective 10 days following the date of filing of the Form 25. The Company’s Class A Ordinary Shares, Units, and Warrants will continue to trade on the OTC Pink Marketplace following the delisting.공시 • Aug 14Enphys Acquisition Corp. announced delayed 10-Q filingOn 08/13/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 26NYSE to Commence Delisting Proceedings Against Enphys AcquisitionThe New York Stock Exchange LLC announced that the staff of NYSE Regulation has determined to commence proceedings to delist Class A ordinary shares, par value 0.0001 per share; Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant and Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary shares at an exercise price of 11.50 of Enphys Acquisition Corp. (the “Company”) from the NYSE. Trading in the Company’s Securities will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.공시 • May 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 02Enphys Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 11/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Oct 31Enphys Acquisition Corp. announced that it has received $0.3 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $300,000 on October 30, 2023. The issuance of the Promissory Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Under the terms of the promissory note, the company may request from time to time prior to the maturity date, up to $300,000 in drawdowns on the principal. Each drawdown request must state the amount to be drawn down, and must not be an amount less than $10,000 unless agreed upon by the company and the payee. Payee shall fund each drawdown request no later than (3) business days after receipt of a drawdown request; provided, however, that the maximum amount of drawdowns outstanding under the promissory note at any time may not exceed $300,000. No fees, payments or other amounts shall be due to the payee in connection with, or as a result of, any drawdown request by the company.공시 • Oct 11Enphys Acquisition Corp. announced that it expects to receive $0.4 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $400,000 on October 10, 2023. Payee or one or more of its affiliates or designees will deposit into the company’s trust account established in connection with its initial public offering an amount equal to the lesser of $0.025 per Class A ordinary share of the company multiplied by the number of Class A ordinary shares of the Company then outstanding and $100,000, for each calendar month until the earlier of the company’s completion of a business combination and February 8, 2024. No interest shall be payable on this note.공시 • May 16Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.매출 및 비용 세부 내역Enphys Acquisition가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:NFSU.F 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비30 Jun 24081031 Mar 240121031 Dec 230151030 Sep 230101030 Jun 230151031 Mar 230121031 Dec 220151030 Sep 220-392030 Jun 220-421031 Mar 220-4510양질의 수익: NFSU.F는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 지난 1년 동안 NFSU.F의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: NFSU.F는 지난 5년 동안 흑자전환했습니다.성장 가속화: NFSU.F은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: NFSU.F은 지난 1년 동안 수익이 감소(-49%)하여 Capital Markets 업계 평균(36.1%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: NFSU.F의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YDiversified-financials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/12/31 16:38종가2024/12/17 00:00수익2024/06/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Enphys Acquisition Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Dec 31Enphys Acquisition Corp. Units, Each Consisting of One Class A Ordinary Share and One-Half of One Redeemable Warrant Deleted from OTC EquityEnphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant has been deleted from OTC Equity effective December 30, 2024, due to Unit Separation.
공시 • Nov 15Enphys Acquisition Corp. Files Form 15Enphys Acquisition Corp. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant; Class A ordinary shares included as part of the Units, par value $0.0001 per share and Redeemable warrants included as part of the Units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share under the Securities Exchange Act of 1934, as amended.
공시 • Oct 17The Staff of NYSE Regulation Files Form 25 with the SEC to Remove Enphys Acquisition's Class A Ordinary Shares, Units from Listing and Registration on the New York Stock ExchangeAs previously reported by Enphys Acquisition Corp. (the ‘Company’), on July 24, 2024, the staff of NYSE Regulation (the ‘Staff’), on behalf of the New York Stock Exchange (‘NYSE’), commenced proceedings to delist the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A Ordinary Shares’), units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant (the ‘Units’), with each warrant exercisable for one share of Class A Ordinary Share of the Company (the ‘Warrants’), and Warrants from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. Trading in the Class A Ordinary Shares, Units, and Warrants on the NYSE was suspended after the market closed on July 24, 2024. Effective as of and since July 25, 2024, the Class A Ordinary Shares, Units, and Warrants have been quoted and traded on the OTC Pink Marketplace under the ticker symbols ‘NFSCF,’ ‘NFSUF,’ and ‘NFSWF,’ respectively. The Company timely exercised its right to a review of the Staff’s determination by a committee (the ‘Committee’) of the Board of Directors of the NYSE. On October 10, 2024, the Company withdrew its request for review by the Committee. On October 10, 2024, the Staff filed a Form 25 with the Securities and Exchange Commission (the ‘SEC’) to remove the Company’s Class A Ordinary Shares, Units, and Warrants from listing and registration on the NYSE. The delisting will be effective 10 days following the date of filing of the Form 25. The Company’s Class A Ordinary Shares, Units, and Warrants will continue to trade on the OTC Pink Marketplace following the delisting.
공시 • Aug 14Enphys Acquisition Corp. announced delayed 10-Q filingOn 08/13/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 26NYSE to Commence Delisting Proceedings Against Enphys AcquisitionThe New York Stock Exchange LLC announced that the staff of NYSE Regulation has determined to commence proceedings to delist Class A ordinary shares, par value 0.0001 per share; Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant and Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary shares at an exercise price of 11.50 of Enphys Acquisition Corp. (the “Company”) from the NYSE. Trading in the Company’s Securities will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
공시 • May 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 02Enphys Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 17Enphys Acquisition Corp. announced delayed 10-Q filingOn 11/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Oct 31Enphys Acquisition Corp. announced that it has received $0.3 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $300,000 on October 30, 2023. The issuance of the Promissory Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Under the terms of the promissory note, the company may request from time to time prior to the maturity date, up to $300,000 in drawdowns on the principal. Each drawdown request must state the amount to be drawn down, and must not be an amount less than $10,000 unless agreed upon by the company and the payee. Payee shall fund each drawdown request no later than (3) business days after receipt of a drawdown request; provided, however, that the maximum amount of drawdowns outstanding under the promissory note at any time may not exceed $300,000. No fees, payments or other amounts shall be due to the payee in connection with, or as a result of, any drawdown request by the company.
공시 • Oct 11Enphys Acquisition Corp. announced that it expects to receive $0.4 million in fundingEnphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $400,000 on October 10, 2023. Payee or one or more of its affiliates or designees will deposit into the company’s trust account established in connection with its initial public offering an amount equal to the lesser of $0.025 per Class A ordinary share of the company multiplied by the number of Class A ordinary shares of the Company then outstanding and $100,000, for each calendar month until the earlier of the company’s completion of a business combination and February 8, 2024. No interest shall be payable on this note.
공시 • May 16Enphys Acquisition Corp. announced delayed 10-Q filingOn 05/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.